Morning Breakouts

Latest KFF Health News Stories

FDA OKs Genetic Tests For Rare Diseases

Morning Briefing

One company, 23andMe, had discontinued the test in late 2013 after the Food and Drug Administration warned it must be approved before marketing. Elsewhere, scrutiny pinches drug compounding companies and a sunscreen law awaits federal review.